Sustainability & Climate

A global coalition of advocates, doctors, and pharma giants launches Obesity Care Week, aiming to dismantle systemic barriers and fight pervasive weight bias.

Donors granted a record $3.9 billion via Vanguard Charitable in 2025, highlighting the growing power and agility of donor-advised funds in philanthropy.

Avenacy launches its 26th product, a generic Benadryl injection, tackling drug shortages and aiming to improve patient safety with unique packaging.

In a strategic reverse merger with Rallybio, T-cell therapy innovator Candid Therapeutics secures over $505M to advance its groundbreaking autoimmune pipeline.

Neogen divests its pioneering genomics business for $160M to slash debt, while Zoetis bolsters its dominance in the animal health diagnostics market.

Zoetis is acquiring Neogen's genomics unit for $160M, a strategic move set to accelerate data-driven innovation in livestock and companion animal care.

Asia's largest pharma show returns, showcasing China's evolution from the world's factory to a global hub of drug innovation and supply chain strategy.

As Mike Eastwood retires, new CFO Gary Bischoping, a tech and finance veteran, is set to guide the company's ambitious AI transformation and next chapter of growth.

The New York-based bank will now originate FHA-insured loans nationwide, positioning it to capitalize on the growing demand for senior care facilities.

At MODEX 2026, KNAPP will unveil its AI-driven 'Brain' and award-winning 3D robots, promising a new era of intelligent, adaptive supply chains.

Industry legend William Sheriff moves to Verdera Energy, unlocking a major New Mexico uranium portfolio in a strategic spin-out from giant enCore Energy.

As childhood nearsightedness soars, a new contact lens offers hope by not just correcting vision but actively slowing its progression in key global markets.

Norwegian Cruise Line reports strong 2025 earnings but a weak 2026 outlook, as its new CEO points to internal missteps and charts a course for recovery.

Argo Biopharma's new CFO/CSO, Dr. Gena Wang, leaves a star analyst career at Barclays, signaling a major validation for the company's siRNA platform.

With star-studded advisory board, a new biotech firm aims to turn routine dental visits into a frontline defense against oral cancer.

A Chinese firm's 'Global Pioneer' status in cellular essence sparks debate on the future of biotech in cosmetics, medicine, and global regulation.

Experience the record-breaking Danjiang Bridge, Zaha Hadid's final work, with pre-opening events before its May 2026 debut. A new wonder rises in Taipei.

With new communities in Fayetteville and Collierville, SRI Management's strategic expansion signals a major move in the booming senior living market.

Shareholder approval paves the way for cancer therapy innovator VERAXA to go public, aiming to accelerate its next-gen antibody-drug conjugate pipeline.

The new Mesa II series promises 800°F searing and rapid assembly at a budget price. Can it redefine value or will durability concerns linger?